XML 110 R83.htm IDEA: XBRL DOCUMENT v3.25.4
Supplemental Financial Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Supplemental Financial Statement Information [Abstract]      
Cash paid for interest $ 4 $ 32 $ 83
Cash paid for income taxes 192 894 670
ROU Asset obtained in exchange for new operating lease liabilities 336 223,853 27,668
Purchases of property and equipment included in accounts payable and accrued expenses 46 2,565 2,915
Convertible financial instruments received for Cell Engineering services 0 0 4,542
Equity securities and warrants received for Cell Engineering services 0 55 17,450
Common stock issued for acquisitions 777 18,245 6,820
Common stock issued as settlement of contingent consideration liabilities 0 14,742 8,896
Common stock issued for retention payments related to business and asset acquisitions 0 5,258 0
Return of investment in equity securities for reduction in deferred revenue 0 6,760 0
Conversion of notes receivable for common stock 0 10,476 0
Issuance costs related to ATM offering included in accounts payable and accrued expenses $ 53 $ 0 $ 0